1.Targeted Treatment for Advanced Solid Tumors (Posted: 12/16/2008) - This clinical trial combines the drug dasatinib with the angiogenesis inhibitor bevacizumab for patients with metastatic or unresectable solid tumors. 2.Chemotherapy for Inoperable Liver Metastases from Ocular Melanoma (Posted: 11/30/2004, Updated: 06/13/2008) - In this study, researchers are testing a procedure called hyperthermic isolated hepatic perfusion to treat inoperable liver metastases secondary to ocular melanoma. 3.Combination Therapy for Advanced Melanoma (Posted: 11/01/2005, Updated: 04/24/2008) - In this clinical trial, researchers are testing chemotherapy with the drugs carboplatin and paclitaxel in combination with a new drug called sorafenib (BAY 43-9006) in patients with advanced melanoma. 4.Extending Immunotherapy for Metastatic Melanoma (Posted: 08/08/2006, Updated: 12/26/2007) - This study will assess the safety and antitumor activity of lymphocytes that have been genetically engineered to recognize the MART-1 antigen in patients with metastatic melanoma. 5.Regional Chemotherapy for Inoperable Liver Metastases (Posted: 10/09/2007) - In this trial, doctors are testing a method of delivering chemotherapy regionally to the liver called percutaneous isolated hepatic arterial perfusion (PHP) in patients with liver metastases from ocular (eye) or cutaneous (skin) melanoma.
